ULSANIC

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

SUCRALFATE 1000 MG

MAH:

TEVA PHARMACEUTICAL INDUST.LTD

ATC_code:

A02BX02

pharmaceutical_form:

TABLETS

administration_route:

PER OS

manufactured_by:

TEVA PHARMACEUTICAL INDUSTRIES LTD

therapeutic_group:

SUCRALFATE

therapeutic_indication:

Ulsanic is indicated in the short-term treatment of duodenal ulcer and gastric ulcer.

authorization_date:

2009-11-01